Manufacturing & Packaging

Flexible Drug Manufacturing

With over 30 years of experience, Groupe PARIMA’s pharmaceutical manufacturing services are defined by scientific precision, operational rigor, and long-term client partnerships.

Integrated R&D and manufacturing teams operating on the same site streamline the entire product lifecycle, from clinical trials to commercial production, ensuring consistent quality and regulatory compliance at every stage.

We specialize in the manufacturing of non-sterile novel, prescription, and OTC drug products, offering unmatched flexibility in batch sizes and formats. Our capabilities span a wide range of dosage forms and packaging configurations, enabling us to deliver turnkey solutions from technology transfer through GMP-compliant release.

Pharmaceutical Manufacturing of Liquids

Scalable Pharma Expertise

Our GMP-compliant facility in Montreal is strategically designed to support a comprehensive range of pharmaceutical manufacturing requirements, from early-stage clinical batches to full-scale commercial production. Engineered for operational flexibility, the site ensures precise execution and efficiency across diverse project scopes.

We are particularly equipped to handle orphan drugs and specialty pharmaceuticals, where precision and responsiveness in small- to mid-scale production are paramount. Our infrastructure and technical expertise enable us to bring complex, niche products to market with the same rigorous quality standards and disciplined processes applied to high-volume programs.

We offer flexible batch sizes across multiple formats:

  • Semi-solids
    • Creams, gels, ointments: 5 to 2,500 kg
    • Lotions: 100 to 4,000 kg
  • Liquids and Suspensions
    • All formats: 20 to 4,000 kg

Our manufacturing suites also offer:

  • Inert gas blanketing
  • Vacuum operation
  • Amber lighting

For volatile or alcohol-based formulations, we operate a dedicated Class 1, Division 1 (1D1) rated explosion-proof suite. Our infrastructure is tailored to meet stringent safety and quality standards, ensuring safe and compliant handling of high-risk materials.

  • Batch sizes from 5 to 1,600 kg

Advanced Manufacturing Equipment

Our pharmaceutical vessels play a central role in ensuring consistency, scalability, and control across a wide range of drug manufacturing operations. Each vessel is selected and configured to meet the specific requirements of the formulation and process stage, supporting critical functions such as mixing, blending, homogenization, and purification. 

Designed to accommodate both routine and complex formulations, our vessels are equipped with advanced features that enable precise control over process parameters, even for products with narrow operating windows or challenging rheological profiles. Our equipment infrastructure supports a wide range of dosage forms and batch sizes, ensuring flexibility without compromising compliance or product integrity.

pharmaceutical tank to manufacture drug products

Our Key Capabilities

  • Fully jacketed tanks with integrated temperature control systems.
  • Sweep and counter-sweep mixing for uniformity and consistency.
  • High-shear homogenizers for emulsification and particle size reduction.
  • Secondary processing equipment: Lightnin Mixers, Rotosolver, Silversion Homogenizers, Colloid Mills, APV systems.
  • Inert atmosphere and vacuum operation for sensitive formulations.
  • Amber lighting for light-sensitive products.

Strategic Supply Chain

We offer a flexible sourcing model that supports client-directed procurement and Groupe PARIMA-sourced components. Every sourcing decision is guided by a rigorous evaluation of cost, quality, and availability to ensure alignment with project requirements and long-term supply objectives.

To safeguard supply chain continuity, we support dual-sourcing strategies for critical materials, ensuring consistent access to essential components and mitigating risk across production cycles.

Global Sourcing Network

Our supplier relationships span North America, particularly the United States and Canada, as well as key markets in Europe. These established networks enable responsive sourcing and reliable access to high-quality materials.

Cost Optimization with Quality Assurance

Our teams continuously assess sourcing options to optimize the cost of goods while maintaining strict quality standards. Alternative suppliers and materials are evaluated to reduce costs where feasible, particularly for long-term commercial supply programs.

Building a Responsible Supply Network

Responsible sourcing is one of our strategic priorities. As we advance our ESG framework, we are embedding these criteria into supplier evaluation and selection. Preference is given to partners with demonstrated commitments to sustainability, ethical practices, and sound governance. It is a step toward building a supply chain that reflects our values and operational goals.

Image by wirestock on Freepik

Logistics Support

During the logistics and supply chain process, we ensure comprehensive logistics support to ensure secure storage and controlled transfer of commercial pharmaceutical products following batch release. Our team coordinates every step of the release and pick-up process, with particular attention to temperature-sensitive and regulatory-bound products.

Controlled On-Site Storage

Finished goods are stored on-site under conditions tailored to each product’s specifications. Both ambient and refrigerated zones are available to support quality release and laboratory testing before shipment.

For products requiring cold chain management (2–8 °C) or ambient (approximately 20 -25°C), we ensure full compliance through validated storage and loading procedures tailored to each drug product’s specifications.

Before shipment, our QA and logistics teams verify that all transport and handling conditions meet defined temperature and quality requirements. This includes the activation of temperature monitoring devices when required, ensuring full traceability and regulatory compliance to release the product.

Packaging That Adapts to Your Product and Market

We offer comprehensive packaging services for drug products developed on-site and those coming from tech transfer. Our packaging operations are tightly integrated with manufacturing and quality systems, ensuring a seamless transition from bulk product to finished drug products ready for market.

Managing both primary and secondary packaging in-house allows for format flexibility, GMP compliance, and robust support for clinical trials and commercial production. Each packaging solution is tailored to meet product-specific requirements, regulatory standards, and market expectations.

We provide end-to-end support for the selection, sourcing, qualification, and implementation of primary packaging formats, tailored to the specific formulation and route of administration of each drug product. Our approach ensures full compatibility with the dosage form and strict adherence to regulatory and quality standards.

Packaging formats are selected based on product characteristics, stability requirements, and market needs, with a focus on performance, patient usability, and compliance.

Available formats include
  • Bottles (plastic or glass)
  • Glass vials
  • Airless pumps
  • Tubes (laminate, aluminum, and metal)
  • Jars and applicators
  • Metered-dose sprays (nasal and sublingual)
  • Unit dose sachets (single and double)
  • Towelettes, wipes, and pads
  • Stick packs
  • Syringe applicators
  • Bag-on-valve systems
Our primary packaging approach includes:

We apply a rigorous, product-specific approach to primary packaging, ensuring full compatibility with the formulation and route of administration. Each packaging solution is selected to meet stringent regulatory requirements for clinical and commercial production. Our packaging strategy includes:

  • Material selection based on formulation characteristics such as viscosity, pH, and volatility.
  • Compatibility testing with liquid, semi-solid, and suspension dosage forms.
  • GMP-compliant sourcing and qualification of all packaging components.
  • Assessment and recommendation of packaging solutions designed to minimize exposure to light and oxygen when required.

We provide robust in-house secondary packaging services designed to support both clinical trial phases and commercial production. Our operations are built on flexibility, scalability, and full GMP compliance, ensuring packaging solutions evolve seamlessly with your drug product throughout its lifecycle.

Capabilities Include:
  • Cartoning, labeling, and tamper-evident sealing
  • Kit assembly and custom configurations for multi-component products
  • Cold-chain packaging workflows for temperature-sensitive products
  • Serialization with full aggregation
  • Custom packaging formats for bulk shipments, clinical trials, and market-ready units

We support differentiated packaging strategies across clinical phases (Phase 1, 2, 3) and commercial launch, ensuring proper documentation, scalability, and regulatory alignment at every stage.

Labeling Solutions

As part of our integrated commercial manufacturing services, we provide comprehensive end-to-end support for product labeling operations, tailored to meet regulatory, technical, and market-specific requirements. We guarantee accurate, compliant, and traceable labeling from the start of production through final release.

Serialization and Aggregation

Our serialization infrastructure supports global compliance, including mandates under DSCSA (U.S.), the EU Falsified Medicines Directive (FMD), and other national regulations. Capabilities include:

  • Application of unique serial numbers to each saleable unit.
  • Serialization with full aggregation across unit, bundle, case, and pallet levels.
  • Generation and management of traceability data files compatible with client systems or third-party track-and-trace providers.
  • Accurate assignment, aggregation, and transfer of serialized data to regulatory or client systems, enabling full downstream traceability and product authentication

Artwork coordination

While our client typically manages commercial artwork development, we work closely with you to ensure smooth integration with manufacturing timelines and packaging specifications. Our team helps mitigate risks related to misprints, non-compliance, and production delays by aligning artwork services with operational and regulatory requirements.

  • Technical guidance on packaging and labeling layouts based on format constraints (tube size, vial diameter, folding carton panels).
  • Support for regulatory and multilingual requirements specific to the target market.
  • Review of print files for GMP and readability compliance prior to production.
  • Collaboration with packaging suppliers to ensure alignment with approved specifications.

Component Expertise and Integration

Packaging decisions made early in the development process can significantly impact product compatibility, manufacturability, and regulatory compliance. Our team provides technical input from the outset to help mitigate downstream risks and ensure smooth integration with production workflows. It includes:

  • Recommending packaging materials based on formulation attributes and stability data.
  • Aligning packaging design with branding and regulatory requirements.
  • Integrate artwork development with technical specifications to ensure manufacturability and compliance.

Why Groupe PARIMA for Pharmaceutical Manufacturing & Packaging?

  • Global reach with more than 45 countries served.
  • High-capacity operations producing 30M units annually.
  • Regulatory compliance with Health Canada, FDA, Europe, Turkey, Australia, and New Zealand.
  • Proven reliability with a 90% Right-First-Time rate for commercial batches.
  • Seamless tech transfer supported by co-located analytical and manufacturing teams.
  • Trusted experience, backed by more than 15 years of continuous commercial supply for our longest-standing clients.